Updates
-
-
A Generic for Ampyra Could Be Released Soon
A few years ago, I had to give up using Ampyra (dalfampridine), the MS medication that can improve walking ... Read more -
Ibudilast Slows Brain Shrinkage 48% in Progressive MS Patients in Phase 2 Trial; Lead Researcher Says Finding is ‘Remarkable’
Progressive multiple sclerosis patients — with primary or secondary progressive disease — treated with high doses of oral ibudilast in a Phase ... Read more -
Grant Awarded to Research New Method to Treat Cognitive Dysfunction in Progressive MS
The Multiple Sclerosis Society of Canada and the Multiple Sclerosis Scientific Research Foundation have awarded a $410,000 grant to fund research ... Read more -
This Is What Excites Me About Remyelination Therapy Research
Remyelination therapies are on the horizon as an innovative multiple sclerosis (MS) treatment, according to my neurologist. These therapies have been on ... Read more -
Gilenya More Effective Than Avonex in Lowering Relapse Rates, New Lesions in Children with Relapsing MS, Phase 3 Trial Shows
Two years of treatment with oral Gilenya (fingolimod) significantly reduced the rate of relapses when compared to Avonex (interferon beta-1a) intramuscular ... Read more
-
-
MS Society of Canada Backs Study of Exercise and Rehabilitation in Aiding Cognition in Progressive Patients
With a $5 million grant, the Multiple Sclerosis Society of Canada ... -
Phase 3 Trial in UK Soon to Test Statin, Simvastatin, in Slowing SPMS Progression
A large Phase 3 trial getting underway at sites across the ... -
Phagocytes, Key Immune Cells, Seen to Switch from Promoting to Repairing MS Lesions in Study
Phagocytes, diverse cells of the innate immune system, are known to ... -
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.
1st Patient Enrolled in Study of Electrical Stimulation in Treating Brain Injury
News
A first patient has been enrolled in a single-site trial to evaluate the potential of electrical stimulation, called Electroceutical Therapy, in reducing brain injury, Endonovo Therapeutics, the therapy’s developer, announced. Electroceutical Therapy is a non-invasive and wearable electronic device ... Read more